Patent details

Basic Information

Publication number:

EP3386975

PCT Application Number:

US2016064379

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP168132744

PCT Publication Number:

WO2017100071

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

5-(5-(2-(3-AMINOPROPOXY)-6-METHOXYPHENYL)-1H-PYRAZOL-3-YLAMINO)PYRAZINE-2-CARBONITRILE (S)-LACTATE MONOHYDRATE

French Title of Invention:

MONOHYDRATE DE 5-(5-(2-(3-AMINOPROPOXY)-6-MÉTHOXYPHÉNYL)-1H-PYRAZOL-3-YLAMINO) PYRAZINE-2-CARBONITRILE (S)-LACTATE

German Title of Invention:

5-(5-(2-(3-AMINOPROPOXY)-6-METHOXYPHENYL)-1H-PYRAZOL-3-YLAMINO)PYRAZIN-2-CARBONITRIL-(S)-LACTAT-MONOHYDRAT

SPC Number:

Dates

Filing date:

01/12/2016

Grant date:

25/09/2019

EP Publication Date:

17/10/2018

PCT Publication Date:

15/06/2017

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

25/09/2019

EP B1 Publication Date:

25/09/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

01/12/2019

Expiration date:

01/12/2036

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

18/09/2019

 

 

Name:

Eli Lilly and Company

Address:

Lilly Corporate Center, Indianapolis, IN 46285, United States (US)

Inventor

Name:

ENNETT-SHEPARD, Alessandra B.

Address:

United States (US)

Priority

Priority Number:

201562263908 P

Priority Date:

07/12/2015

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/497; A61P 35/00; C07D 403/12;

Publication

European Patent Bulletin

Issue number:

201939

Publication date:

25/09/2019

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages